References
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149:315–352. https://doi.org/10.1016/j.chest.2015.11.026
Stein PD, Matta F, Hughes MJ (2017) Inferior vena cava filters in elderly patients with stable acute pulmonary embolism. Am J Med. 130(3):356–364. https://doi.org/10.1016/j.amjmed.2016.09.033
Prisco D, Tufano A, Cenci C, Pignatelli P, Santilli F, Di Minno G, Perticone F (2019) Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer. Intern Emerg Med. 14:21–38. https://doi.org/10.1007/s11739-018-1956-1
Dalla Vestra M, Grolla E, Bonanni L, Pesavento R (2018) Are too many inferior vena cava filters used? Controversial evidences in different clinical settings: a narrative review. Intern Emerg Med 13:145–154. https://doi.org/10.1007/s11739-016-1575-7
Mumoli N, Barco S, Cei M, Giorgi-Pierfranceschi M, Campanini M, Fontanella A, Ageno W, Dentali F (2017) Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians. Intern Emerg Med. 12:437–443. https://doi.org/10.1007/s11739-016-1578-4
PREPIC Study Group (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism. Circulation 112:416–422. https://doi.org/10.1161/circulationaha.104.512834
Mismetti P, Laporte S, Pellerin O et al (2015) Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. J Am Med Assoc. 313:1627–1635. https://doi.org/10.1001/jama.2015.3780
Muriel A, Jiménez D, Aujesky D et al (2014) Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol. 63:1675–1683. https://doi.org/10.1016/j.jacc.2014.01.058
Mellado M, Trujillo-Santos J, Bikdeli B, Jiménez D, Núñez MJ, Ellis M, Marchena PJ, Vela JR, Farès AC, Monreal MM, The RIETE Investigators (2019) Vena caval filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02077-5
Witt DM, Delate T, Garcia DA et al (2012) Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 172:1484–1491. https://doi.org/10.1001/archinternmed.2012.4261
Majeed A, Kim YK, Roberts RS, Holmström M, Schulman S (2010) Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 41:2860–2866. https://doi.org/10.1161/STROKEAHA.110.593087
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement on human and animal rights
This article does not contain data derived by any current studies with human participants performed by any of the authors. The clinical studies mentioned were provided with specific ethical approval.
Informed consent
For this type of study, formal consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Abenante, A., Zuretti, F. & Dentali, F. Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence. Intern Emerg Med 14, 1019–1020 (2019). https://doi.org/10.1007/s11739-019-02107-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-019-02107-2